Fifth Third Bancorp
BNTC icon

Fifth Third Bancorp’s Benitec Biopharma BNTC Stock Holding History

Fifth Third Bancorp’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13K Buy
+106
New +$1.23K ﹤0.01% 4117

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fifth Third Bancorp's BNTC Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Benitec Biopharma (BNTC) in Q1 2026: 106 shares worth $1.13K. The stake represents ﹤0.01% of the portfolio and ranks #4117 among its holdings.

88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Fifth Third Bancorp held 106 shares of Benitec Biopharma worth $1.13K as of Q1 2026.
  • Benitec Biopharma was a new Fifth Third Bancorp position in Q1 2026.
  • Benitec Biopharma made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #4117 holding.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.